# Ballston Spa Bancorp, Inc.: financial statements, quarterly

BSPA · OTC · CIK 2094107 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bspa.md) · [Financials](/companies/bspa/financials.md) · [Filings](/companies/bspa/filings.md) · [Insiders](/companies/bspa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bspa/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Income tax | $k | [305](/filings/0001104659-26-061067.md) | [290](/filings/0001104659-26-097039.md) | [233](/filings/0001104659-26-061067.md) | [(405)](/filings/0001104659-26-097039.md) |
| Net income | $k | [1,301](/filings/0001104659-26-061067.md) | [1,235](/filings/0001104659-26-097039.md) | [244](/filings/0001104659-26-061067.md) | [(711)](/filings/0001104659-26-097039.md) |
| Basic EPS | $ per share | [1.75](/filings/0001104659-26-061067.md) | [1.66](/filings/0001104659-26-097039.md) | [0.33](/filings/0001104659-26-061067.md) | [(0.65)](/filings/0001104659-26-097039.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [28.1](/filings/0001104659-26-097039.md) | [47.8](/filings/0001104659-26-061067.md) | [93.1](/filings/0001104659-26-097039.md) |
| Total assets | $m | not reported | not reported | not reported | [929](/filings/0001104659-26-097039.md) | [942](/filings/0001104659-26-061067.md) | [1,365](/filings/0001104659-26-097039.md) |
| Total liabilities | $m | not reported | not reported | not reported | [857](/filings/0001104659-26-097039.md) | [871](/filings/0001104659-26-061067.md) | [1,270](/filings/0001104659-26-097039.md) |
| Shareholders' equity | $m | [66.2](/filings/0001104659-26-097039.md) | [67.8](/filings/0001104659-26-097039.md) | [69.1](/filings/0001104659-26-097039.md) | [71.1](/filings/0001104659-26-097039.md) | [70.7](/filings/0001104659-26-097039.md) | [94.9](/filings/0001104659-26-097039.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [539](/filings/0001104659-26-061067.md) | [565 d](/filings/0001104659-26-097039.md) | [(588)](/filings/0001104659-26-061067.md) | [1,148 d](/filings/0001104659-26-097039.md) |
| Capital expenditure | $k | [510](/filings/0001104659-26-061067.md) | [352 d](/filings/0001104659-26-097039.md) | [836](/filings/0001104659-26-061067.md) | [650 d](/filings/0001104659-26-097039.md) |
| Dividends paid | $k | [245](/filings/0001104659-26-061067.md) | [245 d](/filings/0001104659-26-097039.md) | [245](/filings/0001104659-26-061067.md) | [372 d](/filings/0001104659-26-097039.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

Shares outstanding: 1,100,071 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.